Discovery of New Binders for DCAF1, an Emerging Ligase Target in the Targeted Protein Degradation Field.
Vulpetti, A., Holzer, P., Schmiedeberg, N., Imbach-Weese, P., Pissot-Soldermann, C., Hollingworth, G.J., Radimerski, T., Thoma, C.R., Stachyra, T.M., Wojtynek, M., Maschlej, M., Chau, S., Schuffenhauer, A., Fernandez, C., Schroder, M., Renatus, M.(2023) ACS Med Chem Lett 14: 949-954
- PubMed: 37465299 
- DOI: https://doi.org/10.1021/acsmedchemlett.3c00104
- Primary Citation of Related Structures:  
8OG5, 8OG6, 8OG7, 8OG8, 8OG9, 8OGA, 8OGB, 8OGC - PubMed Abstract: 
In this study, we describe the rapid identification of potent binders for the WD40 repeat domain (WDR) of DCAF1. This was achieved by two rounds of iterative focused screening of a small set of compounds selected on the basis of internal WDR domain knowledge followed by hit expansion. Subsequent structure-based design led to nanomolar potency binders with a clear exit vector enabling DCAF1-based bifunctional degrader exploration.
Organizational Affiliation: 
Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel 4002, Switzerland.